Robert Linhardt News Today

Scientists in New York and North Carolina say they have assembled the first functioning prototype of an artificial Golgi organelle, a key structure inside cells which helps process and package hormones, enzymes, and other substances that allow the body to function normally.

The brain’s ability to clear a protein closely linked to Alzheimer’s disease is tied to our circadian cycle, according to new research.

The brain's ability to clear a protein closely linked to Alzheimer's disease is tied to our circadian cycle, according to research published today in PLOS Genetics.

A recent study has shown that the brains ability to clear a protein closely linked to Alzheimers disease is linked to the circadian cycle.

Get latest articles and stories on Health at LatestLY. The brains ability to clear a protein closely linked to Alzheimers disease is tied to our circadian cycle, according to a recent study led by the researchers of Rensselaer Polytechnic Institute. Health News | Clearance of Protein Linked to Alzheimers Controlled by Circadian Cycle: Study.

The brains ability to clear a protein closely linked to Alzheimers disease is tied to our circadian cycle, according to a recent study led by the researchers of Rensselaer Polytechnic Institute.

Research underscores the potential importance of healthy sleep habits in preventing formation of amyloid-β 42 protein clumps in the brain.

The brain’s ability to clear a protein closely linked to Alzheimer’s disease is tied to our circadian cycle, according to research published today in

Scientists reprogram a common bacterium to make designer sugar-based drug Envisioning an animal-free drug supply, scientists have -; for the first time -; reprogrammed a common bacterium to make a designer polysaccharide molecule used in pharmaceuticals and nutraceuticals. Published today in Nature Communications, the researchers modified E. coli to produce chondroitin sulfate, a drug best known as a dietary supplement to treat arthritis that is currently sourced from cow trachea. Genetically...

 E-Mail Credit: Rensselaer Polytechnic Institute TROY, N.Y. -- Envisioning an animal-free drug supply, scientists have -- for the first time -- reprogrammed a common bacterium to make a designer polysaccharide molecule used in pharmaceuticals and nutraceuticals. Published today in Nature Communications, the researchers modified E. coli to produce chondroitin sulfate, a drug best known as a dietary supplement to treat arthritis that is currently sourced from cow trachea. Genetically engineered...